WTO Wades Into Vaccine Feud as Merkel, Pharma Balk at Biden Plan

May 6, 2021, 8:10 PM

The pharmaceutical companies hate it. The Biden administration is embracing it. Now, finding common ground for wider distribution of Covid-19 vaccines in poorer countries falls to the World Trade Organization -- a body known more for its inability to do international deals than to clinch them.

Drug companies have a powerful ally in Germany, along with other nations, opposing a waiver of rules protecting the intellectual property behind the vaccines. When the U.S. backed that waiver, it sent shares of American and European vaccine makers tumbling on Wednesday.

Read More: U.S. Vaccine Patent Surprise Roils Pharma as WTO Debate Heats ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.